Search

Your search keyword '"Henderson B.E."' showing total 128 results

Search Constraints

Start Over You searched for: Author "Henderson B.E." Remove constraint Author: "Henderson B.E."
128 results on '"Henderson B.E."'

Search Results

1. Nutritional factors and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort

2. An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

3. Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8).

4. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

5. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1).

6. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8).

7. Oral contraceptive use and adenocarcinoma of cervix

8. A Y chromosomal influence on prostate cancer risk: the multi-ethnic cohort study

9. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)

10. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

11. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

12. Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

13. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

14. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

15. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

16. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

17. Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations: Cancer Research

18. SNP-SNP interaction analysis of NF-kappa B signaling pathway on breast cancer survival

19. SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival

20. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci

21. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

22. Identification of novel genetic markers of breast cancer survival

23. Common germline polymorphisms\ud associated with breast cancer-specific survival

24. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

25. Refined histopathological predictors of BRCA1\ud and BRCA2 mutation status: a large-scale analysis\ud of breast cancer characteristics from the BCAC,\ud CIMBA, and ENIGMA consortia

26. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

27. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

28. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

29. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

30. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

31. A Multigenic Model of Hypertension

32. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

33. Genetic Predisposition to In Situ and Invasive Lobular\ud Carcinoma of the Breast

34. MicroRNA related polymorphisms and breast cancer risk

35. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

36. Prediction of breast cancer risk based on profiling with common genetic variants

37. Identification of novel genetic markers of breast cancer survival

38. Common germline polymorphisms associated with breast cancer-specific survival

39. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

40. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

41. Large-scale genotyping identifies 41 new loci associated with breast cancer risk

42. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians

43. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

44. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

45. MicroRNA related polymorphisms and breast cancer risk

46. Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

47. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

48. 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

49. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

50. Haplotypes of the estrogen receptor beta gene and breast cancer risk

Catalog

Books, media, physical & digital resources